enoxacin has been researched along with Bronchial Pneumonia in 1 studies
Enoxacin: A broad-spectrum 6-fluoronaphthyridinone antibacterial agent that is structurally related to NALIDIXIC ACID.
enoxacin : A 1,8-naphthyridine derivative that is 1,4-dihydro-1,8-naphthyridine with an ethyl group at the 1 position, a carboxy group at the 3-position, an oxo sustituent at the 4-position, a fluoro substituent at the 5-position and a piperazin-1-yl group at the 7 position. An antibacterial, it is used in the treatment of urinary-tract infections and gonorrhoea.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Enoxacin was administered at the dose of 800 mg twice daily by the oral route." | 2.66 | Efficacy and safety of enoxacin in the treatment of respiratory infections. ( Della Torre, F; Fraschini, F; Scaglione, F; Scarpazza, G, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Scarpazza, G | 1 |
| Della Torre, F | 1 |
| Scaglione, F | 1 |
| Fraschini, F | 1 |
1 trial available for enoxacin and Bronchial Pneumonia
| Article | Year |
|---|---|
Efficacy and safety of enoxacin in the treatment of respiratory infections.
Topics: Adult; Aged; Bronchitis; Bronchopneumonia; Clinical Trials as Topic; Enoxacin; Female; Humans; Male; | 1989 |